Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H12 |
| Molecular Weight | 180.2451 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=C(C=C1)\C=C/C2=CC=CC=C2
InChI
InChIKey=PJANXHGTPQOBST-QXMHVHEDSA-N
InChI=1S/C14H12/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-12H/b12-11-
| Molecular Formula | C14H12 |
| Molecular Weight | 180.2451 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| 3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. | 2004-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:56:15 GMT 2025
by
admin
on
Mon Mar 31 18:56:15 GMT 2025
|
| Record UNII |
TTG5048Y3K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
66424
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
(Z)-Stilbene
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
5356785
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
m10216
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | Merck Index | ||
|
TTG5048Y3K
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
36008
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
DTXSID5026049
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
645-49-8
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
211-445-7
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY | |||
|
4270
Created by
admin on Mon Mar 31 18:56:15 GMT 2025 , Edited by admin on Mon Mar 31 18:56:15 GMT 2025
|
PRIMARY |